Olfactory impairment in the rotenone model of parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation

Frontiers in Cellular Neuroscience

Volumn 8, Issue DEC, 2014, Pages

  Rodrigues, Lais S ^a   Targa, Adriano D S ^a   Noseda, Ana Caroiina D ^a   Aurich, Mariana F ^a   Da Cunha, Ciaudio ^a   Lima, Marcelo M S ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bulbar dopaminergic D2 receptors; Dopamine; Intranigral; Olfactory bulb; Olfactory discrimination; Parkinson s disease; REM sleep deprivation

Indexed keywords

DOPAMINE 2 RECEPTOR; GLUCONATE ZINC; NEUROTRANSMITTER; PIRIBEDIL; RACLOPRIDE; ROTENONE; ZINC ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOPAMINERGIC ACTIVITY; EXPERIMENTAL COGNITIVE TEST; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; NEUROCHEMISTRY; NONHUMAN; OLFACTORY BULB; OLFACTORY DISCRIMINATION; OLFACTORY DISCRIMINATION TASK; PARKINSON DISEASE; RAT; REM SLEEP DEPRIVATION; STEREOTAXIC SURGERY; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84920110255     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00383     Document Type: Article

References (61)

1. Alam, M., and Schmidt, W. J. (2004). L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav. Brain Res. 153, 439-446. doi:10.1016/j.bbr.2003.12.021
2. Barbiero, J. K., Santiago, R. M., Lima, M. M., Ariza, D., Morais, L. H., Andreatini, R., et al. (2011).Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson’s disease. Behav. Brain Res. 216, 186-192. doi: 10.1016/j.bbr.2010.07.033
3. Barraud, Q., Lambrecq, V., Forni, C., Mcguire, S., Hill, M., Bioulac, B., et al. (2009). Sleep disorders in Parkinson’s disease: the contribution of the MPTP nonhuman primate model. Exp. Neurol. 219, 574-582. doi: 10.1016/j.expneurol.2009.07.019
4. Benarroch, E. E. (2010). Olfactory system: functional organization and involvement in neurodegenerative disease. Neurology 75,1104-1109. doi: 10.1212/wnl.0b013e3181f3db84
5. Betarbet, R., Sherer, T. B., Mackenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci. 3,1301-1306. doi: 10.1038/81834
6. Bohnen, N. I., Muller, M. L., Kotagal, V., Koeppe, R. A., Kilbourn, M. A., Albin, R. L., et al. (2010). Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133, 1747-1754. doi: 10.1093/brain/awq079
7. Borghammer, P., Knudsen, K., Ostergaard, K., Danielsen, E. H., Pavese, N., Arveschoug, A., et al. (2014). Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders. Int. J. Clin. Pract. 68,1345-1351. doi:10.1111/ijcp.12445
8. Brunig, I., Sommer, M., Hatt, H., and Bormann, J. (1999). Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U S A 96, 2456-2460. doi: 10.1073/pnas.96.5.2456
9. Cagnotto, A., Parotti, L., and Mennini, T.(1996). In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study. Eur. J. Pharmacol. 313, 63-67. doi: 10.1016/0014-2999(96)00503-1
10. Chioca, L. R., Antunes, V. D., Ferro, M. M., Losso, E. M., and Andreatini, R. (2013). Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice. Life Sci. 92, 971-975. doi: 10.1016/j.lfs.2013.03.012
11. Coopersmith, R., Weihmuller, F. B., Kirstein, C. L., Marshall, J. F., and Leon, M. (1991). Extracellular dopamine increases in the neonatal olfactory bulb during odor preference training. Brain Res. 564, 149-153. doi: 10.1016/0006-8993(91)91365-8
12. Coronas, V., Srivastava, L. K., Liang, J. J., Jourdan, F., and Moyse, E.(1997). Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: acombinedin situ hybridization and ligand binding radioautographic approach. J. Chem. Neuroanat. 12, 243-257. doi: 10.1016/s0891-0618(97)00215-9
13. Del Tredici, K., Rub, U., De Vos, R. A., Bohl, J. R., and Braak, H. (2002). Where does parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61, 413-426.
14. Dos Santos, A. C., Castro, M. A., Jose, E. A., Delattre, A. M., Dombrowski, P. A., Da Cunha, C., et al. (2013). REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson’s disease. J. Neurosci. Res. 91, 1508-1516. doi: 10.1002/jnr.23258
15. Doty, R. L. (2012a). Olfaction in Parkinson’s disease and related disorders. Neuro-biol. Dis. 46, 527-552. doi: 10.1016/j.nbd.2011.10.026
16. Doty, R. L. (2012b). Olfactory dysfunction in Parkinson disease. Nat Rev. Neurol. 8, 329-339. doi: 10.1038/nrneurol.2012.28
17. Doty, R. L., and Risser, J. M.(1989). Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology (Berl) 98, 310-315. doi:10.1007/bf00451680
18. Drolet, R. E., Cannon, J. R., Montero, L., and Greenamyre, J. T. (2009). Chronic rotenone exposure reproduces Parkinson’s disease gastrointestinal neuropathology. Neurobiol. Dis. 36, 96-102. doi: 10.1016/j.nbd.2009.06.017
19. Dzirasa, K., Ribeiro, S., Costa, R., Santos, L. M., Lin, S. C., Grosmark, A., et al. (2006). Dopaminergic control of sleep-wake states. J. Neurosci. 26,10577-10589. doi: 10.1523/jneurosci.1767-06.2006
20. Escanilla, O., Yuhas, C., Marzan, D., and Linster, C. (2009). Dopaminergic modulation of olfactory bulb processing affects odor discrimination learning in rats. Behav. Neurosci. 123, 828-833. doi: 10.1037/a0015855
21. Fantini, M. L., Postuma, R. B., Montplaisir, J., and Ferini-Strambi, L. (2006). Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res. Bull. 70, 386-390. doi: 10.1016/j.brainresbull.2006.07.008
22. Giustetto, M., Kirsch, J., Fritschy, J. M., Cantino, D., and Sassoe-Pognetto, M. (1998). Localization of the clustering protein gephyrin at GABAergic synapses in the main olfactory bulb of the rat. J. Comp. Neurol. 395, 231-244. doi: 10.1002/(sici)1096-9861(19980601)395:2<231::aid-cne7>3.0.co;2-3
23. Greenamyre, J. T., Betarbet, R., and Sherer, T. B. (2003). The rotenone model of Parkinson’s disease: genes, environment and mitochondria. Parkinsonism Relat. Disord. 9(Suppl. 2), S59-S64. doi: 10.1016/s1353-8020(03)00023-3
24. Greiner, R. S., Moriguchi, T., Slotnick, B. M., Hutton, A., and Salem, N. (2001). Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 72, 379-385. doi: 10.1016/s0031-9384(00)00437-6
25. Gutierrez-Mecinas, M., Crespo, C., Blasco-Ibanez, J. M., Gracia-Llanes, F. J., Marques-Mari, A. I., Nacher, J., et al. (2005). Distribution of D2 dopamine receptor in the olfactory glomeruli of the rat olfactory bulb. Eur. J. Neurosci. 22,1357-1367. doi: 10.1111/j.1460-9568.2005.04328.x
26. Halasz, N., Ljungdahl, A., Hokfelt, T., Johansson, 〇., Goldstein, M., Park, D., et al. (1977). Transmitter histochemistry of the rat olfactory bulb. I. Immunohisto-chemical localization of monoamine synthesizing enzymes. Support for intra-bulbar, periglomerular dopamine neurons. Brain Res. 126, 455-474. doi: 10.1016/0006-8993(77)90597-2
27. Hsia, A. Y., Vincent, J. D., and Lledo, P. M.(1999). Dopamine depresses synaptic inputs into the olfactorybulb. J. Neurophysiol. 82,1082-1085.
28. Huisman, E., Uylings, H. B., and Hoogland, P. V. (2004). A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov. Disord. 19, 687-692. doi: 10.1002/mds.10713
29. Hutter, J. A., and Chapman, C.A. (2013).Exposure to cues associatedwith palatable food reward results in a dopamine D(2) receptor-dependent suppression of evoked synaptic responses in the entorhinal cortex. Behav. Brain Funct. 9:37. doi: 10.1186/1744-9081-9-37
30. Killgore, W. D., Killgore, D. B., Grugle, N. L., and Balkin, T. J. (2010). Odor identification ability predicts executive function deficits following sleep deprivation. Int. J. Neurosci. 120, 328-334. doi: 10.3109/002074509033 89396
31. Killgore, W. D., Killgore, D. B., Mcbride, S. A., Kaminori, G. H., and Balkin, T. J. (2008a). Odor identification ability predicts chenges in symptoms of psychopathology following 56 h of sleep deprivation. J. Sens. Stud. 23, 35-51. doi: 10.1111/j.1745-459x.2007.00139.x
32. Killgore, W. D., and Mcbride, S. A. (2006). Odor identification accuracy declines following 24 h of sleep deprivation. J. Sleep Res.15,111-116. doi: 10.1111/j.1365-2869.2006.00502.x
33. Killgore, W. D., Mcbride, S. A., Killgore, D. B., Balkin, T. J., and Kamimori, G. H. (2008b). Baseline odor identification ability predicts degradation of psychomotor vigilance during 77 hours of sleep deprivation. Int. J. Neurosci. 118, 1207-1225. doi: 10.1080/00207450801941368
34. Koster, N. L., Norman, A. B., Richtand, N. M., Nickell, W. T., Puche, A.C., Pixley, S. K., et al. (1999). Olfactory receptor neurons express D2 dopamine receptors. J. Comp. Neurol. 411, 666-673. doi: 10.1002/(sici)1096-9861(19990906)411:4<666::aid-cne10>3.0.co;2-s
35. Liberia, T., Blasco-Ibanez, J. M., Nacher, J., Varea, E., Zwafink, V., and Crespo, C. (2012). Characterization of a population of tyrosine hydroxylase-containing interneurons in the external plexiform layer of the rat olfactory bulb. Neuroscience 217, 140-153. doi: 10.1016/j.neuroscience.2012.05.007
36. Lim, J. H., Davis, G. E., Wang, Z., Li, V., Wu, Y., Rue, T. C., et al. (2009). Zicam-induced damage to mouse and human nasal tissue. PLoS One 4:e7647. doi: 10.1371/journal.pone.0007647
37. Lima, M. M. (2013). Sleep disturbances in Parkinson’s disease: the contribution of dopamine in REM sleep regulation. Sleep Med. Re.17, 367-375. doi: 10.1016/j.smrv.2012.10.006
38. Lima, M. M., Andersen, M. L., Reksidler, A. B., Silva, A., Zager, A., Zanata, S. M., et al. (2008). Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behav. Brain Res. 188, 406-411. doi: 10.1016/j.bbr.2007.11.025
39. Lima, M. M., Andersen, M. L., Reksidler, A. B., Vital, M. A., and Tufik, S. (2007). The role of the substantia nigra pars compacta in regulating sleep patterns in rats. PLoS One 2:e513. doi: 10.1371/journal.pone.0000513
40. Lima, M. M., Martins, E. F., Delattre, A. M., Proenca, M. B., Mori, M. A., Carabelli, B., et al. (2012). Motor andnon-motor features ofParkinson’s disease—a review of clinical and experimental studies. CNS Neurol. Disord. Drug Targets 11,439-449. doi: 10.2174/187152712800792893
41. Machado, R. B., Hipolide, D. C., Benedito-Silva, A. A., and Tufik, S. (2004). Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res. 1004, 45-51. doi: 10.1016/j.brainres.2004.01.019
42. McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863-1872. doi: 10.1212/01.wnl.0000187889.17253.b1
43. Moreira, C. G., Barbiero, J. K., Ariza, D., Dombrowski, P. A., Sabioni, P., Bortolanza, M., et al. (2012). Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin. Neurotox. Res. 21,291-301. doi: 10.1007/s12640-011-9278-3
44. Mundinano, I. C., Caballero, M. C., Ordonez, C., Hernandez, M., Dicaudo, C., Marcilla, I., et al. (2011). Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neu-ropathol. 122,61-74. doi: 10.1007/s00401-011-0830-2
45. Nunes Junior, G. P., Tufik, S., and Nobrega, J. N.(1994). Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res. Bull. 34, 453-456. doi: 10.1016/0361-9230(94)90018-3
46. O’Connor, S., and Jacob, T. J. (2008). Neuropharmacology of the olfactory bulb. Curr. Mol. Pharmacol.1,181-190. doi: 10.2174/1874-470210801030181
47. Panzanelli, P., Homanics, G. E., Ottersen, O. P., Fritschy, J. M., and Sassoe-Pognetto, M. (2004). Pre-and postsynaptic GABA receptors at reciprocal dendrodendritic synapses in the olfactory bulb. Eur. J. Neurosci. 20, 2945-2952. doi: 10.1111/j.1460-9568.2004.03776.x
48. Paxinos, G., and Watson, C. (2005). The Rat Brain in Stereotaxic Coordinates. 5th Edn. San Diego: Academic Press.
49. Prediger, R. D., Batista, L. C., and Takahashi, R. N. (2005a). Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors. Neurobiol. Aging 26, 957-964. doi: 10.1016/j.neurobiolaging.2004.08.012
50. Prediger, R. D., Fernandes, D., and Takahashi, R. N. (2005b). Blockade ofadenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats. Behav. Brain Res. 159, 197-205. doi: 10.1016/j.bbr.2004.10.017
51. Saravanan, K. S., Sindhu, K. M., and Mohanakumar, K. P. (2005). Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson’s disease. Brain Res. 1049, 147-155. doi: 10.1016/j.brainres.2005.04.051
52. Segura Aguilar, J., and Kostrzewa, R. M. (2004). Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox. Res. 6, 615-630. doi: 10.1007/bf03033456
53. Sengoku, R., Saito, Y., Ikemura, M., Hatsuta, H., Sakiyama, Y., Kanemaru, K., et al. (2008). Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactorybulb. J. Neuropathol. Exp. Neurol. 67,1072-1083. doi:10.1097/nen.0b013e31818b4126
54. Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., et al. (2003). Mechanism of toxicity in rotenone models of Parkinson’s disease. J. Neurosci. 23, 10756-10764.
55. Siderowf, A., Newberg, A., Chou, K. L., Lloyd, M., Colcher, A., Hurtig, H. I., et al. (2005). [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64, 1716-1720. doi: 10.1212/01.wnl.000016187452302.5d
56. Soffie, M., and Lamberty, Y.(1988). Scopolamine effects on juvenile conspecific recognition in rats: possible interaction with olfactory sensitivity. Behav. Processes 17,181-190. doi: 10.1016/0376-6357(88)90001-0
57. Tillerson, J. L., Caudle, W. M., Parent, J. M., Gong, C., Schallert, T., and Miller, G. W. (2006). Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav. Brain Res. 172, 97-105. doi:10.1016/j.bbr.2006.04.025
58. Tissingh, G., Berendse, H. W., Bergmans, P., Dewaard, R., Drukarch, B., Stoof, J. C., et al. (2001). Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov. Disord.16, 41-46.doi: 10.1002/1531-8257(200101)16:1<41::aid-mds1017>3.0.co;2-m
59. Tufik, S. (1981). Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation. Psychopharmacology (Berl) 72, 257-260. doi:10.1007/bf00431826
60. Tufik, S., Lindsey, C. J., and Carlini, E. A. (1978). Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain? Pharmacology 16, 98-105. doi: 10.1159/000136753
61. Wei, C. J., Linster, C., and Cleland, T. A. (2006). Dopamine D(2) receptor activation modulates perceived odor intensity. Behav. Neurosci. 120, 393-400. doi: 10.1037/0735-7044.120.2.393